| Cardiac resynchronization therapy from cell to bedside: the time has come to focus more on the cell. | |
| | |
MedLine Citation:
|
PMID: 18065281 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Samir Saba |
Publication Detail:
|
Type: Comment; Editorial Date: 2007-10-02 |
Journal Detail:
|
Title: Heart rhythm : the official journal of the Heart Rhythm Society Volume: 5 ISSN: 1547-5271 ISO Abbreviation: Heart Rhythm Publication Date: 2008 Jan |
Date Detail:
|
Created Date: 2008-01-08 Completed Date: 2008-05-07 Revised Date: 2009-10-27 |
Medline Journal Info:
|
Nlm Unique ID: 101200317 Medline TA: Heart Rhythm Country: United States |
Other Details:
|
Languages: eng Pagination: 60-1 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiac Pacing, Artificial* Gene Expression Genetic Markers Heart Failure / genetics, physiopathology, therapy* Humans Ventricular Dysfunction, Left* |
| Chemical | |
Reg. No./Substance:
|
0/Genetic Markers |
| Comments/Corrections | |
Comment On:
|
Heart Rhythm. 2008 Jan;5(1):52-9
[PMID:
18082469
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Interventricular mechanical dyssynchrony: a novel marker of cardiac events in Brugada syndrome.
Next Document: Does diabetes affect weight loss after gastric bypass?